CYBIN INC.
For the period ended Mar 31, 2025. Filed Jul 1, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Jul 1, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Difficulty to Forecast
Difficulty to Forecast
The Company must rely largely on its own market research to forecast sales as detailed forecasts are not generally obtainable from other sources at this early stage of the psychedelic pharmaceutical industry. A failure in the demand for the Company’s psychedelic pharmaceutical industry products to materialize as a result of competition, technological change or other factors could have a material adverse effect on the business, results of operations and financial condition of the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.